GlassScriptPhysician profile
Jennifer Rizzo
NPI 1720548613
$1,127.46
in general payments reported to CMS, 2019-2025
21 companies · $444 in 2025
The $444 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.03 · 2023: $109 · 2024: $553 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,106.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $150.12 | 2023-2025 | Veozah |
| Sage Therapeutics, LLC | $148.94 | 2024-2025 | Zurzuvae |
| Gynesonics, INC. | $95.83 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sumitomo Pharma America, INC. | $92.55 | 2023-2025 | Myfembree |
| Organon LLC | $71.42 | 2024-2025 | Jada System |
| Hologic Sales and Service, LLC | $63.75 | 2024-2025 | Aptima, Thinprep 2000 Processor, Novasure |
| Mayne Pharma Commercial LLC | $62.49 | 2024-2025 | |
| Conmed Corporation | $55.10 | 2024-2025 | Airseal |
| Coopersurgical, INC. | $54.98 | 2023-2025 | Advincula Delineator Uterine Manipulator, Paragard T 380a, Mara Console |
| Mimedx Group, INC. | $51.71 | 2024-2025 | |
| Dilon Technologies, INC. | $49.37 | 2024 | Hemoblast Bellows |
| Pfizer INC. | $40.90 | 2023 | |
| Exeltis, USA INC. | $31.29 | 2024-2025 | Slynd |
| Boston Scientific Corporation | $29.40 | 2024 | |
| Abbvie INC. | $23.90 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $23.77 | 2024 | |
| Merck Sharp & Dohme LLC | $21.03 | 2019 | |
| Exact Sciences Corporation | $18.13 | 2025 | The Cologuard Plus Collection Kit |
| Shield Therapeutics INC | $14.73 | 2024 | |
| Supernus Pharmaceuticals, INC. | $14.38 | 2025 | Qelbree |
| Meditrina | $13.67 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Rizzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.